Aadi Bioscience, Inc. (AADI) Misses Q2 EPS by 5c, revenue in-line

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q2 EPS of ($0.67), $0.05 worse than the analyst estimate of ($0.62). Revenue for the quarter came in at $6.2 million versus the consensus estimate of $6.2 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Carvana (CVNA) PT Lowered to $85 at RBC Capital
• Aspire Biopharma to acquire automotive supplier for $30 million